Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals' Other Non Operating Income history spans 3 years, with the latest figure at $169000.0 for Q4 2024.

  • On a quarterly basis, Other Non Operating Income rose 121.13% to $169000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $169000.0, a N/A change, with the full-year FY2025 number at $389000.0, up 130.18% from a year prior.
  • Other Non Operating Income hit $169000.0 in Q4 2024 for Eton Pharmaceuticals, up from -$800000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for ETON hit a ceiling of $800000.0 in Q2 2023 and a floor of -$800000.0 in Q4 2023.
  • Historically, Other Non Operating Income has averaged $133500.0 across 3 years, with a median of $267000.0 in 2021.
  • The widest YoY moves for Other Non Operating Income: up 121.13% in 2024, down 121.13% in 2024.
  • Tracing ETON's Other Non Operating Income over 3 years: stood at $365000.0 in 2021, then tumbled by 319.18% to -$800000.0 in 2023, then surged by 121.12% to $169000.0 in 2024.
  • Business Quant data shows Other Non Operating Income for ETON at $169000.0 in Q4 2024, -$800000.0 in Q4 2023, and $800000.0 in Q2 2023.